Lodovico Bergamo-Di

Bellinzona, TI, Switzerland

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 33 publications

Interim assessment by circulating tumor DNA in primary mediastinal large B-cell lymphoma: a multicenter LYSA study.

Interim assessment by circulating tumor DNA in primary mediastinal large B-cell lymphoma: a multicenter LYSA study.

Journal: Blood advances
Published: November 14, 2025

Interim assessment by circulating tumor DNA in primary mediastinal large B-cell lymphoma: a multicenter LYSA study.

Interim assessment by circulating tumor DNA in primary mediastinal large B-cell lymphoma: a multicenter LYSA study.

Journal: Blood advances
Published: November 14, 2025

Dissecting clonal hematopoiesis in the myeloid compartment of chronic lymphocytic leukemia and Richter transformation.

Dissecting clonal hematopoiesis in the myeloid compartment of chronic lymphocytic leukemia and Richter transformation.

Journal: HemaSphere
Published: July 22, 2025

IL-16 production is a mechanism of resistance to BTK inhibitors and R-CHOP in lymphomas.

IL-16 production is a mechanism of resistance to BTK inhibitors and R-CHOP in lymphomas.

Journal: bioRxiv : the preprint server for biology
Published: July 14, 2025

IL-16 production is a mechanism of resistance to BTK inhibitors and R-CHOP in lymphomas.

IL-16 production is a mechanism of resistance to BTK inhibitors and R-CHOP in lymphomas.

Journal: Blood
Published: May 14, 2025

IL-16 production is a mechanism of resistance to BTK inhibitors and R-CHOP in lymphomas.

IL-16 production is a mechanism of resistance to BTK inhibitors and R-CHOP in lymphomas.

Journal: Blood
Published: May 14, 2025

Integration of [18F]FDG-PET radiomics with liquid biopsy improves outcome prediction in newly diagnosed diffuse large B-cell lymphoma.

Integration of [18F]FDG-PET radiomics with liquid biopsy improves outcome prediction in newly diagnosed diffuse large B-cell lymphoma.

Journal: Leukemia
Published: February 05, 2025

The immune cell dynamics in the peripheral blood of cHL patients receiving anti-PD1 treatment.

The immune cell dynamics in the peripheral blood of cHL patients receiving anti-PD1 treatment.

Journal: Frontiers in oncology
Published: October 28, 2024

A comprehensive genetic study of classic Hodgkin lymphoma using circulating tumor DNA.

A comprehensive genetic study of classic Hodgkin lymphoma using circulating tumor DNA.

Journal: Blood
Published: October 23, 2024

Molecular clustering on ctDNA improves the prognostic stratification of patients with DLBCL compared with ctDNA levels.

Molecular clustering on ctDNA improves the prognostic stratification of patients with DLBCL compared with ctDNA levels.

Journal: Blood advances
Published: July 19, 2024

Early reappearance of intraclonal proliferative subpopulations in ibrutinib-resistant chronic lymphocytic leukemia.

Early reappearance of intraclonal proliferative subpopulations in ibrutinib-resistant chronic lymphocytic leukemia.

Journal: Leukemia
Published: January 12, 2024

Baseline circulating tumour DNA and interim PET predict response in relapsed/refractory classical Hodgkin lymphoma.

Baseline circulating tumour DNA and interim PET predict response in relapsed/refractory classical Hodgkin lymphoma.

Journal: British journal of haematology
Published: August 13, 2023
Showing 1-12 of 33

Last Updated: 09/26/2026